By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Auris Medical AG 

Falknerstrasse 4

Basel    4001  Switzerland
Phone: 41-61-201-13-50 Fax: 41-61-201-13-51


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Auris Medical AG (EARS) Reports Second Quarter 2014 Financial Results and Provides Business Update 9/15/2014 7:59:30 AM
Auris Medical AG (EARS) To Announce Second Quarter 2014 Financial Results And Host Conference Call On Monday, September 15, 2014 9/8/2014 10:23:32 AM
Auris Medical AG (EARS) Announces Exercise Of IPO Over-Allotment Option 8/20/2014 7:35:20 AM
Auris Medical AG (EARS) Announces Closing of Initial Public Offering 8/11/2014 11:47:40 AM
Auris Medical AG (EARS) Prices IPO At $6 A Share, Raises $56 Million 8/6/2014 7:00:36 AM
Auris Medical AG Commences Proposed Initial Public Offering Of Common Shares 7/21/2014 7:36:05 AM
Published Analysis Confirms Positive Results From Auris Medical AG's Phase 2b Study With AM-101 In Treatment Of Acute Inner Ear Tinnitus 3/31/2014 9:01:12 AM
Auris Medical AG Announces Enrollment Of First Patient In North American Phase 3 Study Of AM-101 In Treatment Of Acute Peripheral Tinnitus 3/10/2014 9:12:37 AM
Auris Medical AG Announces Enrollment Of First Patient In European Phase 3 Study Of AM-101 In Treatment Of Acute Peripheral Tinnitus 2/21/2014 8:55:18 AM
Auris Medical AG Reaches Special Protocol Assessment Agreement With FDA for Pivotal Phase III Clinical Trial With AM-101 in Treatment of Acute Peripheral Tinnitus 11/4/2013 9:40:11 AM
1234
//-->